What does SymBio Pharmaceuticals Limited do?
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an…
What is SymBio Pharmaceuticals Limited's P/E and P/B ratio?
SymBio Pharmaceuticals Limited has a P/E ratio of -0.5 and a P/B ratio of -6.46.
What is SymBio Pharmaceuticals Limited's debt-to-equity ratio?
SymBio Pharmaceuticals Limited has a debt-to-equity ratio of 1.56.
How much does SymBio Pharmaceuticals Limited owe compared with what it owns?
SymBio Pharmaceuticals Limited owes ¥1.31 for every ¥1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is SymBio Pharmaceuticals Limited's Positivity rank?
SymBio Pharmaceuticals Limited is ranked #10,459 of 10,750 companies globally and #3,671 of 3,683 in Japan on PositoAI, with a Positivity Score of -22,195.
Does SymBio Pharmaceuticals Limited have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Red flags (PosiRed) are not checked yet for companies in this market on PositoAI, so no result is shown for SymBio Pharmaceuticals Limited.
Where can I read the latest news about SymBio Pharmaceuticals Limited?
Recent headlines about SymBio Pharmaceuticals Limited from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does SymBio Pharmaceuticals Limited have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of SymBio Pharmaceuticals Limited's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.